Novo CEO pressed by Senate to chop charges of being overweight, diabetes medication CEO Lars Fruergaard Jørgensen informed lawmakers the corporate would take into consideration new talks with insurers in regards to the record charges of Wegovy and copyright should they pledge to help keep the medicines on their formularies. https://andymopop.dgbloggers.com/31041267/everything-about-healthcare-news